Clinical Trials Browser

Immunoblastic Lymphadenopathy, Lymphoma, Recurrence, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Epstein-Barr Virus Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

A Phase I/II Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors

T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma

Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

PINNACLE

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies

oHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection

ALIVE

A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC

Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC

Pancreatic

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

APL-102 Capsule in Patients With Advanced Solid Tumors

A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors

Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors

AN0025 and Chemoradiotherapy Combination in Esophageal Cancer

A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors

A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG

A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer

Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

DNX-2440 for Resectable Colorectal Liver Metastasis

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b)

Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)

T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma

First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma

LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer

IMAGINE

Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia

TR1801-ADC in Patients With Tumors That Express c-Met

Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients

Safety and Efficacy Evaluation of CD19-UCART

A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer

Safety and Activity Study of HER2-Targeted Dual Switch CAR-T Cells (BPX-603) in Subjects With HER2-Positive Solid Tumors

Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma

Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer

A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor

A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma

CLL004

Efficacy and Safety Evaluation of BCMA-UCART

Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics